Mechanisms of Direct Inhibitory Action of Ketamine on Vascular Smooth Muscle in Mesenteric Resistance Arteries


    loading  Checking for direct PDF access through Ovid

Abstract

BackgroundKetamine was previously suggested to relax vascular smooth muscle by reducing the intracellular Ca2+ concentration ([Ca2+]i). However, no direct evidence is available to indicate that ketamine reduces the [Ca2+]i in vascular smooth muscle of systemic resistance arteries.MethodsEndothelium-intact or -denuded smooth muscle strips were prepared from rat small mesenteric arteries. Isometric force and [Ca2+]i were measured simultaneously in the fura-2–loaded, endothelium-denuded strips. In some experiments, only isometric force was measured in either the endothelium-intact or β-escin–treated, endothelium-denuded strips.ResultsIn the endothelium-intact strips, lower concentrations (≤ 30 μm) of ketamine slightly enhanced norepine-phrine-induced contraction, whereas higher concentrations (≥ 100 μm) of ketamine inhibited both norepinephrine- and KCl-induced contractions. In the fura-2–loaded strips, ketamine (≥ 100 μm) inhibited the increases in both [Ca2+]i and force induced by either norepinephrine or KCl. Ketamine also inhibited the norepinephrine-induced increase in [Ca2+]i after treatment with ryanodine. In the absence of extracellular Ca2+, ketamine notably inhibited the norepinephrine-induced increase in [Ca2+]i, whereas it only minimally inhibited caffeine-induced increase in [Ca2+]i. Ketamine had little influence on the [Ca2+]i–force relation during force development to stepwise increment of extracellular Ca2+ concentration during either KCl depolarization or norepinephrine stimulation. Ketamine did not affect Ca2+-activated contractions in the β-escin membrane–permeabilized strips.ConclusionsThe action of ketamine on contractile response to norepinephrine consists of endothelium-dependent vasoconstricting and endothelium-independent vasodilating components. The direct vasorelaxation is largely a result of reduction of [Ca2+]i in vascular smooth muscle cells. The [Ca2+]i-reducing effects are caused by inhibitions of both voltage-gated Ca2+ influx and norepinephrine-induced Ca2+ release from the intracellular stores.

    loading  Loading Related Articles